Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
53.30
+0.60 (1.14%)
Nov 21, 2024, 11:49 AM EST - Market open
Exact Sciences Employees
Exact Sciences had 6,600 employees as of December 31, 2023. The number of employees increased by 200 or 3.13% compared to the previous year.
Employees
6,600
Change (1Y)
200
Growth (1Y)
3.13%
Revenue / Employee
$407,928
Profits / Employee
-$32,430
Market Cap
9.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6,600 | 200 | 3.13% |
Dec 31, 2022 | 6,400 | -100 | -1.54% |
Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
Dec 31, 2020 | 5,000 | 890 | 21.65% |
Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
Dec 31, 2018 | 1,977 | 709 | 55.91% |
Dec 31, 2017 | 1,268 | 532 | 72.28% |
Dec 31, 2016 | 736 | 59 | 8.71% |
Dec 31, 2015 | 677 | 441 | 186.86% |
Dec 31, 2014 | 236 | 134 | 131.37% |
Dec 31, 2013 | 102 | 15 | 17.24% |
Dec 31, 2012 | 87 | 26 | 42.62% |
Dec 31, 2011 | 61 | 26 | 74.29% |
Dec 31, 2010 | 35 | 16 | 84.21% |
Dec 31, 2009 | 19 | 15 | 375.00% |
Dec 31, 2008 | 4 | -10 | -71.43% |
Dec 31, 2007 | 14 | -8 | -36.36% |
Dec 31, 2006 | 22 | -27 | -55.10% |
Dec 31, 2005 | 49 | -22 | -30.99% |
Dec 31, 2004 | 71 | -11 | -13.41% |
Dec 31, 2003 | 82 | 7 | 9.33% |
Dec 31, 2002 | 75 | 7 | 10.29% |
Dec 31, 2001 | 68 | 24 | 54.55% |
Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Charles River Laboratories International | 21,800 |
Catalent | 17,800 |
Qiagen | 5,967 |
Medpace Holdings | 5,900 |
Sarepta Therapeutics | 1,314 |
Exelixis | 1,310 |
EXAS News
- 1 day ago - Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript) - Seeking Alpha
- 3 days ago - Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community - Business Wire
- 7 days ago - Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy - Business Wire
- 11 days ago - Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap. - Seeking Alpha
- 14 days ago - Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount - Investopedia
- 15 days ago - Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point - Benzinga
- 15 days ago - Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 15 days ago - Exact Sciences Corporation (EXAS) Q3 2024 Earnings Call Transcript - Seeking Alpha